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WITHOUT CLEAR RULES, PTAB PRACTICES MAY RUN
AFOUL OF THE APA
ARPITA BHATTACHARYYA & RACHEL L. EMSLEY*
INTRODUCTION
Like all administrative agencies of the United States, the internal procedures of the United States Patent and Trademark Office (USPTO) and its
judicial arm—the Patent Trial and Appeal Board (PTAB)—are governed by
the Administrative Procedure Act (APA). 1 The APA imposes procedural
requirements for all formal adjudications before the PTAB, including inter
partes review (IPR), post-grant review (PGR), and Covered Business
Method review (CBM).2 Under the APA, each interested party is entitled
to receive a timely notice of “the matters of fact and law asserted,” an opportunity to submit and consider facts and arguments, and “to submit rebuttal
evidence . . . as may be required for a full and true disclosure of the facts.” 3
The Federal Circuit has explained that the APA imposes limits on the
PTAB’s actions and procedures, and that the PTAB may not “change theories in midstream” without giving the adversely affected party reasonable
notice of the change and the opportunity to respond under the new theory.4
The codified rules for PTAB procedure—the American Invents Act
(AIA) Statute and USPTO Trial Practice Regulations5—do not themselves
ensure APA compliance. In other words, simply following these rules does
not guarantee that the proceeding will meet the APA’s notice and opportunity to respond requirements. Instead, as explained below, parties must be
vigilant and take measures to establish a favorable record for appeal, i.e.,
one that establishes the APA violation or that protects against such a
claim. This article explores one area that has emerged as a fertile ground
 Arpita Bhattacharyya, Ph.D. is an associate in the Palo Alto office and Rachel L. Emsley is an associate
in the Boston office of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. The authors extend their
gratitude to Joshua Goldberg, partner in the DC office of Finnegan, for his guidance in drafting this article.
1. Dell Inc. v. Acceleron, LLC, 818 F.3d 1293, 1298 (Fed. Cir. 2016); see also SAS Inst., Inc.
v. ComplementSoft, LLC., 825 F.3d 1341, 1351 (Fed. Cir. 2016).
2. See 5 U.S.C. §§ 551–559 (2012); see also Dell, 818 F.3d at 1301.
3. Dell, 818 F.3d at 1301; see also Belden Inc. v. Berk-Tek LLC., 805 F.3d 1064, 1080 (Fed.
Cir. 2015); 5 U.S.C. §§ 554(b)–(c), 556(d) (2012).
4. Belden, 805 F.3d at 1080.
5. See America Invents Act, 35 U.S.C. §§ 311–29 (2012); see also 37 C.F.R. § 42 (2017).
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for APA issues: when a party presents “new argument” late in the proceeding but the PTAB’s rules do not provide a clear path for the opposing
party to respond.
This Article begins with a review of the PTAB procedures for presentation of arguments and evidence in Part I. Part II explores the contours of
APA violations as established by the Federal Circuit thus far. Finally, in Part
III, this Article discusses the evolving PTAB practice for handling new arguments and proposes best practices for avoiding or establishing APA issues
on appeal.
I.

PTAB PRACTICE

PTAB rules and procedures, and ultimately the Congressional mandate
to conclude review in one year from institution,6 limit the parties’ ability to
present evidence and argument.7 The petitioner bears the burden in the initial
filing to submit, up front, the evidence and arguments it will rely upon in a
14,000 words IPR petition or 18,700 words PGR/CBM petition.8 If the
PTAB institutes a trial, the patent owner submits a substantive response in
14,000 words (for IPR) or 18,700 words (for PGR/CBM), and the petitioner
is allowed a single, shorter reply (5,600 words for IPR, PGR, and CBM) to
the patent owner’s arguments.9 The rules provide no further right to substan-

6. 35 U.S.C. § 316(a)(11) (2012) (“requiring that the final determination in an inter partes
review be issued not later than 1 year after the date on which the Director notices the institution of a
review under this chapter, except that the Director may, for good cause shown, extend the 1-year
period by not more than 6 months, and may adjust the time periods in this paragraph in the case of
joinder under section 315(c)”).
7. See, e.g., 37 C.F.R. § 42.23 (2016) (explaining that “[a] reply may only respond to arguments raised in the corresponding opposition, patent owner preliminary response, or patent owner
response.”); id. at § 42.24 (establishing type-volume or page-limits for petitions, motions, oppositions, and replies).
8. 35 U.S.C. § 312(a)(3) (2012) (requiring that “the petition identifies, in writing and with
particularity, each claim challenged, the grounds on which the challenge to each claim is based, and
the evidence that supports the grounds for the challenge to each claim”); see also id. at § 316(e) (“In
an inter partes review instituted under this chapter, the petitioner shall have the burden of proving a
proposition of unpatentability by a preponderance of the evidence.”); 37 C.F.R. § 42.24(a) (2016)
(setting word limit for petitions).
9. 35 U.S.C. § 316 (a)(8) (2012) (providing for the filing by the patent owner of a response to the
petition under Section 313 after an inter partes review has been instituted, and requiring that the patent
owner file with such response, through affidavits or declarations, any additional factual evidence and
expert opinions on which the patent owner relies in support of the response); see also id. at § 316(a)(13)
(providing the petitioner with at least one opportunity to file written comments within a time period established by the Director); 37 C.F.R. § 42.120(a) (2012) (“patent owner may file a response to the petition
addressing any ground for unpatentability not already denied. A patent owner response is filed as an
opposition and is subject to the page limits provided in § 42.24”); id. at § 42.24(b)(2) (“The word counts
for a patent owner response to petition are the same as the word counts for the petition”); id. at § 42.23(b)
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tive briefing. In fact, the PTAB has generally established that no new evidence may be introduced at the oral hearing and that the parties’ demonstratives must find support in the record, which generally precludes any meaningful response to arguments that have not been addressed previously in the
proceeding.10 This tightly-controlled process can give rise to APA violations
when, for example, a petitioner raises new arguments in its reply, but the
PTAB rules do not guarantee patent owner a sur-reply.11 Similarly, a patent
owner may raise substantial issues, such as secondary considerations, in its
response, but petitioner may not be able to respond adequately to those issues
in its reply given the word-count limits and the need to respond to arguments
on the merits of the instituted grounds. At present, PTAB practice for handling new arguments is highly variable, with no clear guidance from the
PTAB or the Federal Circuit on what parties must do to avoid or raise APA
issues on appeal.
II.

CONTRASTING FEDERAL CIRCUIT DECISIONS ON “NEW
ARGUMENTS” PRESENTED POST-INSTITUTION

Recent Federal Circuit cases shed some light on how new arguments
presented by a party in a patent owner response or in a petitioner’s reply, or
a new position adopted by the PTAB in the final written decision, may or
may not violate the APA. In In re NuVasive, Inc., for example, the Federal
Circuit provided insight into how new arguments presented by a petitioner
after institution, i.e., arguments not in the petition, can run afoul of the
APA.12
In re NuVasive, Inc. involved two companion IPR petitions filed by
Medtronic against a NuVasive patent.13 Both petitions focused on the obviousness of certain dimensions for a spinal fusion implant.14 In the first Petition (IPR2013-00507), Medtronic argued that it would have been obvious to

(“[a] reply may only respond to arguments raised in the corresponding opposition, patent owner preliminary response, or patent owner response.”); id. at § 42.24(c)(1) (limiting reply to 5,600 words).
10. See Office Patent Trial Practice Guide, 77 Fed. Reg. 48,756, 48,768 (Aug. 14, 2012) (codified
at 37 C.F.R. pt. 42) (“No new evidence or arguments may be presented at the oral argument.”); see also
CBS Interactive Inc. v. Helferich Patent Licensing, LLC, IPR2013-00033, Paper 118, at 3 (P.T.A.B. Oct.
23, 2013) (cautioning that new arguments “would include different characterizations of the evidence and
different inferences drawn from the evidence. If certain testimony previously was not developed, discussed, or explained in a party’s papers, it may not be developed, discussed, explained, or summarized,
for the first time, in the form of demonstrative slides at final oral hearing.”).
11. See infra Part III.
12. 841 F.3d 966 (Fed. Cir. 2016).
13. Id. at 967.
14. Id.
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modify the primary reference in view of a secondary reference, Michelson,
stating that Michelson teaches the “elongated shape” and “dimensions that
are longer than wide,” with a citation to a range in Michelson including a
discussion of its Figure 18.15 In the second Petition (IPR2013-00508), Medtronic relied on a different primary reference, modified by Michelson, but
did not include any assertion about, or citation to, Michelson’s Figure 18.16
In response to NuVasive’s patent owner responses arguing that no single reference taught the claimed dimensions, Medtronic pointed to Michelson’s
Figure 18 in both of its replies. The PTAB denied NuVasive’s request for
leave to file motions to strike the new argument, or in the alternative, to file
sur-replies.17 And, at oral argument, the PTAB did not allow NuVasive to
make substantive arguments in response to Medtronic’s reliance on Figure
18 of Michelson, and when NuVasive objected to Medtronic’s argument regarding Figure 18 during its rebuttal time, the panel “assured NuVasive that
it understood [its] position and would consider the propriety of Medtronic’s
arguments when making a final decision.”18
The Federal Circuit found the notice to NuVasive of Medtronic’s reliance on Figure 18 of Michelson was “minimally sufficient” in IPR201300507, despite the fact that Medtronic did not make a “clear or direct reference to [the length/width ratio claim] limitation or a clear or direct assertion
that the [claimed] ratio is shown in Michelson, in Figure 18 or elsewhere.”19
But in the appeal of IPR2013-00508, the Federal Circuit found that Medtronic’s petition did not notify NuVasive of the portions of Michelson that
later became critical in the proceeding and that the PTAB’s ultimate reliance
on that material, together with its refusal to allow NuVasive to file a surreply or address the matter during oral argument, amounted to a violation of
the notice and opportunity to respond provisions of the APA.20 The Federal
Circuit further noted that although NuVasive was allowed to file “observations” on the cross-examination of Medtronic’s expert, the “observations”
were not sufficient to ensure the required opportunity to respond.21
This case stands in contrast to the Federal Circuit’s decision on the
PTAB’s handling of claim construction issues in Intellectual Ventures II LLC

15.
16.
17.
18.
19.
20.
21.

Id. at 969.
Id.
Id. at 970.
Id.
Id. at 972.
Id. at 972–73.
Id. at 973.
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v. Ericsson Inc.22 There, patent owner Intellectual Ventures argued that its
procedural due process rights under the APA were violated by the PTAB’s
adoption of a claim construction in its final written decision that no party
previously advanced.23 Specifically, Intellectual Ventures contended that
neither Ericsson nor Google (who filed separate IPR petitions) offered a construction of the term in their respective petitions and that “the Board never
‘previewed’ its construction until the Google oral argument.”24
The Federal Circuit disagreed because claim construction of that particular term was extensively litigated by both parties and the panel questioned
the parties about the construction at oral hearing.25 Notably, the Federal Circuit explained that Intellectual Ventures had an opportunity to seek a surreply after it became aware of Google’s and Ericsson’s claim construction
positions in their respective replies, but it did not do so.26 Nor did Intellectual
Ventures seek rehearing after the final written decision was issued.27 Based
on these facts, the Federal Circuit found no violation of the notice and opportunity to respond requirements of the APA.28 Presumably, had Intellectual Ventures asked for a sur-reply or a rehearing on the claim construction
matter, but was denied, and/or the PTAB had not allowed Intellectual Ventures to address the matter during oral hearing, Intellectual Ventures could
have more plausibly argued under In re NuVasive that there was an APA
violation. Because claim construction of the term was at issue throughout the
proceedings, and further because Intellectual Ventures did not seek additional briefing and was in fact given an opportunity to respond during oral
arguments, any supposed APA violation resulting from the PTAB’s adoption
of the new claim construction seemed to have been cured.29
Similarly, in Genzyme Therapeutic Prods. L.P. v. Biomarin Pharm.
Inc., patent owner Genzyme argued that the PTAB violated the APA when

22. 686 F. App’x 900 (Fed. Cir. 2017).
23. Id. at 904–05.
24. Id.
25. Id. at 905. But see Rovalma, S.A., v. Bohler-Edelstahl GMBH & Co. KG, 856 F.3d 1019, 1029
(Fed. Cir. 2017) (remanding and noting that “although the Board discussed [certain submissions] extensively at the oral argument, that was too late in the absence of an additional adequate opportunity to be
heard.”).
26. Intellectual Ventures II, 686 F. App’x at 905–06.
27. Id.
28. Id.
29. See id. at 906.
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it cited references in its final written decisions that were not specifically included in the instituted prior art grounds for two IPR proceedings.30 The Federal Circuit, however, explained that introduction of new evidence during the
course of the trial was “perfectly permissible under the APA,” as long as
opposing party is given notice of the evidence and has an opportunity to respond to it.31 Considering the specific facts of the case, the Federal Circuit
concluded that there was no APA violation because Genzyme had “ample
notice that the references were in play as potentially relevant evidence” and,
in fact, had argued against the references in its patent owner responses.32
III.

NEW ARGUMENTS: AN UNSETTLED PTAB PRACTICE

Thus far, the PTAB has not adopted a standard procedure for enabling
parties to identify or respond to new arguments introduced following institution.33 To avail oneself of the argument that the APA has been violated,
however, a party may have to attempt all avenues to respond.34 In Belden
Inc. v. Berk-Tek LLC, the Court noted the various processes a patent owner
may use:
[I]f the petitioner submits a new expert declaration with its
Reply, the patent owner can respond in multiple ways. It can
cross-examine the expert and move to file observations on
the cross-examination. It can move to exclude the declaration. It can dispute the substance of the declaration at oral
hearing before the Board. It can move for permission to submit a surreply responding to the declaration’s contents. And
it can request that the Board waive or suspend a regulation
that the patent owner believes impairs its opportunity to respond to the declaration. The options are not mutually exclusive.35

30. 825 F.3d 1360, 1366 (Fed. Cir. 2016).
31. Id.
32. Id. at 1367.
33. Belden Inc. v. Berk-Tek LLC., 805 F.3d 1064, 1081 (Fed. Cir. 2015) (noting that “a party
may cross-examine an affiant who has submitted testimony prepared for review”, “move for additional
discovery,” “move to exclude evidence” and “‘[i]n the event that cross-examination occurs after a party
has filed its last substantive paper on an issue . . . [t]he Board may authorize the filing of observations on
that cross examination, though the observations are to be brief and non-argumentative.”).
34. Id. at 1079.
35. Id. at 1081.
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Thus, it is up to the parties to identify “new” arguments to the panel and
seek relief. In Belden, the Court held that the PTAB “provided Belden with
a meaningful opportunity to respond . . . in that it granted every request
Belden made for consideration of the issue.”36 However, Belden did not seek
to file a sur-reply, observations on its cross-examination, or to otherwise
have the PTAB waive regulations preventing it from responding to a new
declaration submitted with the petitioners’ reply.37 Therefore, the Court did
not feel “prepared to find Belden was denied a meaningful opportunity to
respond.”38
Our study of PTAB decisions reveals that the opportunity to respond to
new arguments may be more limited than the Federal Circuit has considered.
Although the Court commented that a party can make a motion to exclude
evidence or dispute “the substance . . . at oral hearing before the Board,” the
PTAB does not generally allow parties to use a motion to exclude or oral
hearing to present arguments outside of those already in the briefing.39 And
while the Court cited several cases in which the Board allowed parties to file
sur-replies to a petitioner’s replies,40 the PTAB’s response to such requests
for sur-replies has been varied.41 In cases where the patent owner has raised

36. Id. at 1082.
37. Id.
38. Id.
39. See Office Patent Trial Practice Guide, 77 Fed. Reg. 48,768 (“No new evidence or arguments
may be presented at the oral argument.”); see also CBS Interactive Inc. v. Helferich Patent Licensing,
LLC, IPR2013-00033, 2012 WL 9496444, at *3 (cautioning that new arguments “would include different
characterizations of the evidence and different inferences drawn from the evidence. If certain testimony
previously was not developed, discussed, or explained in a party’s papers, it may not be developed, discussed, explained, or summarized, for the first time, in the form of demonstrative slides at final oral
hearing.”); Apple Inc. v. VOIP-PAL.com, Inc., IPR2016-01201, Paper 43 (P.T.A.B. Dec. 20, 2017)
(denying motion to expunge but noting “we advise the parties that, to the extent that Patent Owner’s
Motion to Exclude amounts to an unauthorized sur-reply or seeks to exclude Petitioner’s argument in its
Reply, such content is not proper for a motion to exclude.”).
40. Belden, 805 F.3d at 1081 (citing Sensio, Inc. v. Select Brands, Inc., IPR2013-00580, 2015 WL
1009189, at *1, *4–7 (P.T.A.B. Feb. 9, 2015); Zodiac Pool Sys., Inc. v. Aqua Prods., Inc., IPR201300159, 2014 WL 4244016, at *1, *22 (P.T.A.B. Aug. 22, 2014); ABB, Inc. v. ROY–G–BIV Corp.,
IPR2013-00063, 2014 WL 2112556, at *4 (P.T.A.B. May 16, 2014)).
41. See, e.g., Campbell Soup Co. v. Gamon Plus, Inc., IPR2017-00087, IPR2017-00091, IPR201700094, Paper 41, at 3 (P.T.A.B. Nov. 14, 2017) (sur-reply granted); Arris Int’l PLC v. Sony Corp.,
IPR2016-00835, Paper 29 (P.T.A.B. May 26, 2017) (sur-reply granted); Coal. for Afford. Drugs VI, LLC
v. Celgene Corp., Nos. IPR2015-01092, IPR2013-01096, IPR2015-01102, IPR2015-01103, Paper 65
(P.T.A.B. Jun. 24, 2016) (sur-reply granted); Instradent USA, Inc. v. Nobel Biocare Servs. AG, IPR201501786, Paper 57 (P.T.A.B. Aug. 16, 2016) (sur-reply granted); ShenZhen Liown Elec. Co., v. Disney
Enters., Inc., IPR2015-01656, IPR2015-01657, IPR2015-01658, Paper 35 (P.T.A.B. Sept. 2, 2016) (surreply denied); Cisco Sys., Inc. v. TQ Delta, LLC, IPR2016-01007, Paper 20 (P.T.A.B. Jun. 22, 2017)
(sur-reply denied); Coherus Biosciences Inc. v. AbbVie Biotech. Ltd., IPR2016-00172, IPR2016-00188,
IPR2016-00189, Paper 46 (P.T.A.B. Jan. 20, 2017) (sur-reply denied); Kranos Corp. v. Riddel, Inc.,
IPR2016-01646, IPR2016-01650, Paper 23 (P.T.A.B. Oct. 16, 2017) (sur-reply denied); Nintendo of Am.,
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secondary considerations, or attempted to swear behind a prior art reference—issues on which the patent owner bears the ultimate burden of proof—
the Board has allowed a sur-reply so that the patent owner has the “final
word.”42 But, even in such cases or in cases where a new reference has been
introduced by the petitioner in its reply, the PTAB has denied reply briefing
in many instances.43 With many of these denials, the PTAB has taken the
view that “the Board, sitting as a non-jury tribunal with administrative expertise, is well positioned to determine and assign appropriate weight to evidence and arguments presented in the briefs, including giving it no weight
if, for example, the evidence is improperly offered.”44 Instead, the usual
course taken by the PTAB has been to allow the aggrieved party to submit a
short paper identifying the location of allegedly new arguments—cautioning
that the paper should not make any arguments—and allow the responding
party to submit a paper pointing to the original support.45
CONCLUSION
While the process may be uncertain, petitioners and patent owners must
be vigilant to identify new arguments post-institution to the PTAB and to
pursue every available remedy including responsive substantive briefing.
Without such vigilance, a party may find itself unable to make a successful
APA claim on appeal. In pursuit of a clear and full record, parties should
memorialize conference calls with the Board, where decisions and arguments
may otherwise be made off-the-record, by hiring a Court Reporter and filing
transcripts as exhibits.46 And, as oral hearing transcripts become part of the
record for appeal, parties may use that opportunity to memorialize what may
otherwise not be made off-record. Although it has not gained wide acceptance at the PTAB, some panels may allow an offer of proof under Fed.

Inc. v. Motion Games, LLC, IPR2014-0164, IPR2014-00165, IPR2014-00166, Paper 27 (P.T.A.B. Nov.
26, 2014) (sur-reply denied).
42. See, e.g., Campbell Soup, Paper 41, at 3 (noting Patent Owner bears the burden of producing
evidence in the form of secondary considerations of non-obviousness).
43. See, e.g., ShenZhen, Paper 35; Coherus, Paper 46.
44. Kranos, Paper 23.
45. See, e.g., Cisco, Paper 20; Nintendo, Paper 34.
46. See Ultratec, Inc. v. CaptionCall, LLC, 872 F.3d 1267, 1274–75 (Fed. Cir. 2017) (finding no
burden on the patentee to memorialize the agency reasoning, and noting that the USPTO’s Patent Trial
Practice Guide and website does not inform parties that they have the right to hire a stenographer to
transcribe conference calls).
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R. Civ. P. 103(a)(2)47 to be made by submission or at the Oral Hearing.48
Finally, in the face of a request for additional briefing by an opponent, parties
should consider whether to oppose such requests, as a denial may give rise
to a reversal or remand from the Federal Circuit for an APA violation.

47. FED. R. EVID. 103(a)(2) (“A party may claim error in a ruling to admit or exclude evidence only
if the error affects a substantial right of the party and . . . if the ruling excludes evidence, a party informs
the court of its substance by an offer of proof, unless the substance was apparent from the context.”).
48. See, e.g., Juniper Networks, Inc. v. Chrimar Sys. Inc., IPR2016-01397, Paper 66, at *54, *60
(P.T.A.B. Dec. 29, 2017) (noting offer of proof submitted at Oral Hearing); Samsung Elec. Co., LTD, v.
Affinity Labs of Tex., LLC, IPR2014-00209, Paper 51, at *78–80 (P.T.A.B. Apr. 3, 2015) (allowing party
to make offer of proof at Oral Hearing). But see Int’l Bus. Machs. Corp., v. Intellectual Ventures II LLC,
IPR2015-01323, Paper 35 (P.T.A.B. Jul. 11, 2016) (denying petitioner’s request for rehearing on denial
of petitioner’s request for authorization to file offer of proof).

